|
NIH-Led Scientists Find Antibodies that Prevent Most HIV Strains from Infecting Human Cells |
|
Monday, 19 July 2010 |
Discovery to Advance HIV Vaccine Design, Antibody Therapy for Other Diseases
July 8, 2010 - Scientists have discovered two potent human antibodies that can stop
more than 90 percent of known global HIV strains from infecting human
cells in the laboratory, and have demonstrated how one of these
disease-fighting proteins accomplishes this feat. According to the
scientists, these antibodies could be used to design improved HIV
vaccines, or could be further developed to prevent or treat HIV
infection. Moreover, the method used to find these antibodies could be
applied to isolate therapeutic antibodies for other infectious diseases
as well.
“The discovery of these exceptionally broadly neutralizing
antibodies to HIV and the structural analysis that explains how they
work are exciting advances that will accelerate our efforts to find a
preventive HIV vaccine for global use,” says Anthony S. Fauci, M.D.,
director of the National Institute of Allergy and Infectious Diseases
(NIAID), National Institutes of Health. “In addition, the technique the
teams used to find the new antibodies represents a novel strategy that
could be applied to vaccine design for many other infectious diseases.”
|
|
Read more...
|
|
BD Biosciences grants to support stem cell research in flow cytometry |
|
Monday, 28 June 2010 |
San Diego--
June 18, 2010 BD Biosciences, a segment of BD (Becton, Dickinson and Company) will
further expand its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research in multicolor flow cytometry, as well as cell signaling, cancer research, immune function, infectious diseases and neuroscience.
The
focus of the new stem cell research grants is to support the continuing
study of embryonic, adult and induced pluripotent stem cells to improve
the understanding of both normal and disease processes.
"Even
though the peak of the economic crisis appears to already have been
reached, life scientists in the United States are still in desperate
need for resources to keep their research projects alive," said Robert
Balderas, Vice President of Biological Sciences, BD Biosciences. "BD
Biosciences is proud to do its part to help advance some of the most
promising stem cell and immunology research that could one day help
cure or prevent disease."
When added to the existing $140,000
allocated to support immunology research, this new funding will bring
the total annual support amount to $240,000, which will be distributed
via 24 individual grants of BD Biosciences research reagents, cell
culture tools and labware valued at $10,000 each.
Additional information about the grant program, including the application process and deadlines, is available at www.bdbiosciences.com/grant.
|
|
|
TheScientist.com profiles data analysis software |
|
Thursday, 24 June 2010 |
|
Want to learn more about post acquisition data analysis systems without having to purchase and test them all yourself? TheScientist.com recently published an article featuring an overview, including pros and cons, of the leading flow cytometry data analysis software on the market. Read it here.
|
|
|
New type of stem cell could be more useful for research |
|
Monday, 21 June 2010 |
|
Reported on the Harvard website on June 8, 2010, Harvard Stem Cell Institute (HSCI) researchers at
the Massachusetts General Hospital Center for Regenerative
Medicine (MGH-CRM) have a developed a new type of human pluripotent stem
cell that can be manipulated more readily than currently available stem cells. As described in
the latest edition of Cell Stem Cell, these new cells could
be used to create better cellular models of disease processes and eventually
may permit repair of disease-associated gene mutations.
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
